Cargando…

Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome

Altered gut microbiota are assumed to be involved in the pathogenesis of irritable bowel syndrome (IBS). However, gut microbiota alterations reported in different studies are divergent and sometimes even contradictory. To better elucidate the relationship between altered gut microbiota and IBS, we c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuang, Xiaojun, Tian, Zhenyi, Li, Li, Zeng, Zhirong, Chen, Minhu, Xiong, Lishou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068233/ https://www.ncbi.nlm.nih.gov/pubmed/30090090 http://dx.doi.org/10.3389/fmicb.2018.01600

Ejemplares similares

The propionic acid and butyric acid in serum but not in feces are increased in patients with diarrhea-predominant irritable bowel syndrome
por: Tian, Zhenyi, et al.
Publicado: (2020)

Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome
por: Zhuang, Xiaojun, et al.
Publicado: (2020)

Prevalence of lactose intolerance in patients with diarrhea-predominant irritable bowel syndrome: data from a tertiary center in southern China
por: Xiong, Lishou, et al.
Publicado: (2017)

Alterations in short-chain fatty acids and serotonin in irritable bowel syndrome: a systematic review and meta-analysis
por: Luo, Mei, et al.
Publicado: (2021)

Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome
por: Xiao, Lin, et al.
Publicado: (2021)

Fecal Microbiota Transplantation Combined with a Low FODMAP Diet for the Treatment of Irritable Bowel Syndrome with Predominant Diarrhea
por: Huang, Hong-Li, et al.
Publicado: (2022)

The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome
por: Mazzawi, Tarek, et al.
Publicado: (2021)

Mucosal-Associated Microbiota Other Than Luminal Microbiota Has a Close Relationship With Diarrhea-Predominant Irritable Bowel Syndrome
por: Yang, Min, et al.
Publicado: (2020)

Gut Microbiota Profile in Pediatric Patients With Inflammatory Bowel Disease: A Systematic Review
por: Zhuang, Xiaojun, et al.
Publicado: (2021)

Golden bifid might improve diarrhea-predominant irritable bowel syndrome via microbiota modulation
por: Luo, Mei, et al.
Publicado: (2022)

Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease
por: Lo Presti, Alessandra, et al.
Publicado: (2019)

Altered profiles of fecal metabolites correlate with visceral hypersensitivity and may contribute to symptom severity of diarrhea-predominant irritable bowel syndrome
por: Zhang, Wen-Xue, et al.
Publicado: (2019)

Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome
por: Mei, Lijun, et al.
Publicado: (2021)

The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors
por: Lin, Hao, et al.
Publicado: (2021)

Targeted therapies for diarrhea-predominant irritable bowel syndrome
por: Olden, Kevin W
Publicado: (2012)

Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome
por: Lacy, Brian E
Publicado: (2016)

Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
por: Özdener, Ayşe Elif, et al.
Publicado: (2017)

Food Additives Associated with Gut Microbiota Alterations in Inflammatory Bowel Disease: Friends or Enemies?
por: Liu, Caiguang, et al.
Publicado: (2022)

Altered Intestinal Microbiota with Increased Abundance of Prevotella Is Associated with High Risk of Diarrhea-Predominant Irritable Bowel Syndrome
por: Su, Tingting, et al.
Publicado: (2018)

Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome
por: Wei, Wei, et al.
Publicado: (2020)

Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome
por: Carroll, Ian M, et al.
Publicado: (2010)

Fecal Microbiota of Diarrhea-Predominant Irritable Bowel Syndrome Patients Causes Hepatic Inflammation of Germ-Free Rats and Berberine Reverses It Partially
por: Jia, Qiong, et al.
Publicado: (2019)

Abnormal Uroguanylin Immunoreactive Cells Density in the Duodenum of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Changes following Fecal Microbiota Transplantation
por: Mazzawi, Tarek, et al.
Publicado: (2020)

Clinical characteristic and fecal microbiota responses to probiotic or antidepressant in patients with diarrhea-predominant irritable bowel syndrome with depression comorbidity: a pilot study
por: Zhang, Lu, et al.
Publicado: (2019)

Evaluation of the effectiveness and mechanism of action of the Chang-Kang-Fang formula combined with bifid triple viable capsules on diarrhea-predominant irritable bowel syndrome
por: Sun, Jing, et al.
Publicado: (2023)

Misinterpreting Diarrhea-Predominant Irritable Bowel Syndrome and Functional Diarrhea: Pathophysiological Highlights
por: Sciumè, Giusi Desirè, et al.
Publicado: (2023)

Characterization of kynurenine pathway in patients with diarrhea-predominant irritable bowel syndrome
por: Li, Pingping, et al.
Publicado: (2020)

Diarrhea-Predominant Irritable Bowel Syndrome: Medical Management Update
por: Andrews, Christopher N, et al.
Publicado: (2019)

Electroacupuncture for patients with diarrhea-predominant irritable bowel syndrome or functional diarrhea: A randomized controlled trial
por: Zheng, Hui, et al.
Publicado: (2016)

Prokaryotic and Eukaryotic Fecal Microbiota in Irritable Bowel Syndrome Patients and Healthy Individuals Colonized With Blastocystis
por: Nourrisson, Céline, et al.
Publicado: (2021)

Intestinal Fibrosis and Gut Microbiota: Clues From Other Organs
por: Zhan, Shukai, et al.
Publicado: (2021)

Colonic Gene Expression and Fecal Microbiota in Diarrhea-predominant Irritable Bowel Syndrome: Increased Toll-like Receptor 4 but Minimal Inflammation and no Response to Mesalazine
por: Jalanka, Jonna, et al.
Publicado: (2021)

Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome
por: Wang, Zhe, et al.
Publicado: (2019)

Effects of an oral synbiotic on the gastrointestinal immune system and microbiota in patients with diarrhea-predominant irritable bowel syndrome
por: Moser, Adrian Mathias, et al.
Publicado: (2018)

A Clostridia-rich microbiota enhances bile acid excretion in diarrhea-predominant irritable bowel syndrome
por: Zhao, Ling, et al.
Publicado: (2019)

Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
por: Sobolewska-Włodarczyk, Aleksandra, et al.
Publicado: (2016)

A protease activity-based machine-learning approach as a complementary tool for conventional diagnosis of diarrhea-predominant irritable bowel syndrome
por: Tanaka, Kazuki, et al.
Publicado: (2023)

Association of Fecal Microbiota with Irritable Bowel Syndrome-Diarrhea and Effect of Traditional Chinese Medicine for Its Management
por: Yang, Fang, et al.
Publicado: (2021)

Comparison of Quality of Life and Psychiatric Symptoms Between Patients With Diarrhea-Predominant Irritable Bowel Syndrome and Those With Constipation-Predominant Irritable Bowel Syndrome
por: BOUSABA, J., et al.
Publicado: (2023)

Efficacy and Safety of Acupoint Catgut Embedding for Diarrhea-Predominant Irritable Bowel Syndrome and Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
por: Wu, Jing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_or4mc7lrgtq48q4362l8ges7dq